The role of home sleep testing for evaluation of patients with excessive daytime sleepiness: focus on obstructive sleep apnea and narcolepsy

被引:25
作者
Rosenberg, Russell [1 ]
Hirshkowitz, Max [2 ]
Rapoport, David M. [3 ]
Kryger, Meir [4 ]
机构
[1] Neurotrials Res Inc, 1100 Johnson Ferry Rd,Suite 420, Atlanta, GA 30342 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Mt Sinai Integrat Sleep Ctr, New York, NY USA
[4] Yale Pulm & Crit Care Med, New Haven, CT USA
关键词
Home sleep testing; Polysomnography; Obstructive sleep apnea; Narcolepsy; Diagnosis; Screening; CLINICAL-PRACTICE GUIDELINE; LABORATORY POLYSOMNOGRAPHY YIELD; RESIDUAL SLEEPINESS; AMERICAN ACADEMY; SUBJECTIVE SLEEPINESS; DELAYED DIAGNOSIS; EPIDEMIOLOGY; PREVALENCE; POPULATION; COMORBIDITY;
D O I
10.1016/j.sleep.2019.01.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Excessive daytime sleepiness (EDS) is a common complaint in the general population, which may be associated with a wide range of sleep disorders and other medical conditions. Narcolepsy is a sleep disorder characterized primarily by EDS, which involves a substantial burden of illness but is often overlooked or misdiagnosed. In addition to identifying low cerebrospinal fluid (CSF) hypocretin (orexin) levels, evaluation for narcolepsy requires in-laboratory polysomnography (PSG). Polysomnography is the gold standard for diagnosis of obstructive sleep apnea (OSA) as well as other sleep disorders. However, the use of home sleep apnea testing (HSAT) to screen for OSA in adults with EDS has increased greatly based on its lower cost, lower technical complexity, and greater convenience, versus PSG. The most commonly used, types 3 and 4, portable monitors for HSAT lack capability for electroencephalogram recording, which is necessary for the diagnosis of narcolepsy and other sleep disorders and is provided by PSG. These limitations, combined with the increased use of HSAT for evaluation of EDS, may further exacerbate the underrecognition of narcolepsy and other hypersomnias, either as primary or comorbid disorders with OSA. Adherence to expert consensus guidelines for use of HSAT is essential. Differential clinical characteristics of patients with narcolepsy and OSA may help guide correct diagnosis. Continued EDS in patients diagnosed and treated for OSA may indicate comorbid narcolepsy or another sleep disorder. Although HSAT may diagnose OSA in appropriately selected patients, it cannot rule out or diagnose narcolepsy. Therefore, at present, PSG and MSLT remain the cornerstone for narcolepsy diagnosis. (C) 2019 The Authors. Published by Elsevier B.V.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 118 条
[1]   Obstructive sleep apnea during rapid eye movement sleep: clinical relevance and therapeutic implications [J].
Alzoubaidi, Mohammed ;
Mokhlesi, Babak .
CURRENT OPINION IN PULMONARY MEDICINE, 2016, 22 (06) :545-554
[2]  
[Anonymous], OBSTR SLEEP APN TREA
[3]  
[Anonymous], NAT I HLTH SLEEP DIS
[4]  
[Anonymous], JAMA
[5]  
[Anonymous], CURR OTORHINOLARYNGO
[6]  
[Anonymous], SLEEP BREATH
[7]  
[Anonymous], SLEEP REV
[8]  
[Anonymous], PSYCHOSOCIAL ASPECTS
[9]  
[Anonymous], ATT POL EV SLEEP DIS
[10]  
[Anonymous], CAG00093R2 SERV DOHA